Polymeric composition for ocular devices
Polymeric and co-polymeric compositions useful for preparing ophthalmic and ocular devices, such as implantable intraocular lenses (IOL) and contact lenses, and processes of forming the compositions and devices are provided. The disclosed polymeric or co-polymeric composition may include a curcuminoid compound as a UV-blocker, and is derived from a pre-polymerization mixture of monomers which comprises at least 50 weight percents acrylate monomers and exhibiting visible light transparency and ultraviolet light opacity. The disclosed co-polymeric composition may alternatively, or in addition, be derived from a pre-polymerization mixture of defined monomers.
1. A co-polymeric composition comprising a polymeric backbone composed of a plurality of backbone units covalently linked to one another, said backbone units being derived from a pre-polymerization mixture of monomers which comprises:
a first aromatic acrylate monomer, characterized as forming a first homopolymer having a refractive index that ranges from 1.50 to 1.53;
a second aromatic acrylate monomer, characterized as forming a second homopolymer having a Tg lower by a range of 2° C. to 30° C. than a Tg of said first homopolymer;
a third monomer, characterized as forming a third homopolymer having a Tg lower than 35° C.;
a fourth monomer, characterized as forming a fourth homopolymer which is capable of absorbing water to at least 20% of the total weight of said fourth homopolymer; and
a fifth monomer, being a crosslinking monomer,
wherein:
a concentration of said first aromatic acrylate monomer ranges from 50% to 60% of the total weight of the composition;
a concentration of said second aromatic acrylate monomer ranges from 15% to 20% of the total weight of the composition;
a concentration of said third monomer ranges from 10% to 15% of the total weight of the composition;
a concentration of said fourth monomer ranges from 5% to 10% of the total weight of the composition;
a concentration of said fifth monomer ranges from 2% to 5% of the total weight of the composition; and
the composition is characterized by a glass transition temperature not higher than 5° C. and being formulated for ophthalmic application, wherein the composition is characterized by at least one of: a loop pull force mechanical strength of at least 60 grams; a Shore A hardness that ranges from 77 to 80; and an unfolding time of less than 6 seconds.
2. The composition of claim 1 , further comprising an ultraviolet absorbing compound.
3. The composition of claim 1 , wherein:
a concentration of said first aromatic acrylate monomer ranges from 52% to 59% of the total weight of the composition;
said concentration of said second aromatic acrylate monomer ranges from 15% to 19% of the total weight of the composition;
said concentration of said third monomer ranges from 11% to 15% of the total weight of the composition;
said concentration of said fourth monomer ranges from 7% to 9% of the total weight of the composition; and
said concentration of said fifth monomer ranges from 2% to 3.5% of the total weight of the composition.
4. The composition of claim 1 , wherein said mixture further comprises a free radical polymerization initiator.
5. The composition of claim 1 , wherein said mixture further comprises a curing agent.
6. The composition of claim 1 , further comprising at least one curcuminoid compound incorporated therein or thereon.
7. The composition of claim 6 , wherein a concentration of said curcuminoid compound ranges from 0.0002 weight percentage to 1 weight percentage of the total weight of the composition.
8. The composition of claim 7 , wherein said concentration of said curcuminoid compound decreases by less than 0.0001 weight percentage when the composition is subjected to a solvent extraction.
9. A process of preparing the composition of claim 1 , the process comprising:
admixing said pre-polymerization mixture of monomers and a free radical polymerization initiator;
heating said pre-polymerization mixture to 40° C. while stirring until a viscosity reach 120 cps at 25° C.;
degassing said pre-polymerization mixture so as remove volatile residues;
admixing an additional amount of said initiator into said pre-polymerization mixture so as to obtain a reaction mixture;
admixing a curing agent into said reaction mixture;
casting said reaction mixture into a mold; and
exposing said reaction mixture to curing conditions, to thereby obtain the composition.
10. The process of claim 9 , further comprising, subsequent to said exposing said reaction mixture to said curing conditions:
subjecting the composition to a multiple extraction.
11. An ophthalmic or ocular device, comprising the composition of claim 1 .
12. The ophthalmic or ocular device of claim 11 , selected from the group consisting of an intraocular lens (IOL), a contact lens, an implantable ocular device, a keratoprosthesis, a phakic lens, an aphakic lens, a corneal ring, a capsular bag extension ring, a corneal inlay and a corneal onlay.
13. A co-polymeric composition comprising a polymeric backbone composed of a plurality of backbone units covalently linked to one another and a curcuminoid compound incorporated in or on the composition, said backbone units being derived from a pre-polymerization mixture of monomers which comprises:
a first aromatic acrylate monomer, characterized as forming a first homopolymer having a refractive index that ranges from 1.50 to 1.53;
a second aromatic acrylate monomer, characterized as forming a second homopolymer having a Tg lower by a range of 2° C. to 30° C. than a Tg of said first homopolymer;
a third monomer, characterized as forming a third homopolymer having a Tg lower than 35° C.;
a fourth monomer, characterized as forming a fourth homopolymer which is capable of absorbing water to at least 20% of the total weight of said fourth homopolymer; and
a fifth monomer, being a crosslinking monomer,
wherein:
a concentration of said first aromatic acrylate monomer ranges from 50% to 60% of the total weight of the composition;
a concentration of said second aromatic acrylate monomer ranges from 15% to 20% of the total weight of the composition;
a concentration of said third monomer ranges from 10% to 15% of the total weight of the composition;
a concentration of said fourth monomer ranges from 5% to 10% of the total weight of the composition;
a concentration of said fifth monomer ranges from 2% to 5% of the total weight of the composition; and
the composition is characterized by a glass transition temperature not higher than 5° C. and being formulated for ophthalmic application, wherein the composition is characterized by at least one of: a loop pull force mechanical strength of at least 60 grams; a Shore A hardness that ranges from 77 to 80; and an unfolding time of less than 6 seconds.
14. The composition of claim 13 , wherein:
a concentration of said first aromatic acrylate monomer ranges from 52% to 59% of the total weight of the composition;
said concentration of said second aromatic acrylate monomer ranges from 15% to 19% of the total weight of the composition;
said concentration of said third monomer ranges from 11% to 15% of the total weight of the composition;
said concentration of said fourth monomer ranges from 7% to 9% of the total weight of the composition; and
said concentration of said fifth monomer ranges from 2% to 3.5% of the total weight of the composition.
15. The composition of claim 13 , wherein said mixture further comprises a free radical polymerization initiator.
16. The composition of claim 13 , wherein said mixture further comprises a curing agent.
17. The composition of claim 13 , having a visible light transmission of at least 97% of incident visible light.
18. The composition of claim 13 , having a refractive index of at least 1.53.
19. The composition of claim 13 , having loop pull force mechanical strength of at least 60 grams.
20. The composition of claim 13 , characterized by Shore A hardness that ranges from 77 to 80.
21. The composition of claim 13 , having an unfolding time of less than 6 seconds.
22. The composition of claim 13 , having a leachable content of less than 0.6%.
23. The composition of claim 13 , wherein a concentration of said curcuminoid compound ranges from 0.0002 weight percentage to 1 weight percentage of the total weight of the composition.
24. The composition of claim 23 , wherein said concentration of said curcuminoid compound decreases by less than 0.0001 weight percentage when the composition is subjected to a solvent extraction.
25. An ophthalmic or ocular device, comprising the composition of claim 13 .
26. The device of claim 25 , selected from the group consisting of an intraocular lens (IOL), a contact lens, an implantable ocular device, a keratoprosthesis, a phakic lens, an aphakic lens, a corneal ring, a capsular bag extension ring, a corneal inlay and a corneal onlay.
27. The composition of claim 13 , further characterized by at least one of:
a visible light transmission of at least 97% of incident visible light; and
a refractive index of at least 1.53.